This report covers vital information and detailed analysis of the dressings, wound-closure, compression-therapy, haemostats, tissue sealants, negative pressure wound therapy (NPWT), silver antimicrobial dressings and many more for Brazil, Asia-Pacific countries such as Japan, South Korean and Australia and U.S. along with fifteen European countries which include Austria, Belgium, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and U.K.
Key findings of the report
- The European wound and tissue management market is valued to be €3.46 billion, whereas the Brazilian wound and tissue market is valued at $632 million USD and there is an exponential economic growth in their respective markets.
- Along with the growing economy and increasing healthcare expenditures, technological developments such as silver-embedded antimicrobial dressings and negative pressure wound therapy are also driving the Brazilian market. Whereas in Europe, this market is expected to be mainly driven by an aging population and rising rates of diabetes, obesity, and heart disease.
- Negative Pressure Wound Therapy & Reimbursements (NPWT) is relatively new and becoming very popular for wound management. The market has experienced strong growth since it has been developed by Kinetic Concepts Inc, (KCI) which had a monopoly on the market for a number of years.
- As per the survey conducted in fifteen European countries, the market for NPWT grew at nearly 5% in 2012 mainly due to increased competition and the release of new disposable pumps. Whereas in Brazil, NPWT is the fastest growing segment in the wound and tissue management market and is expected to exponentially rise, since NPWT was officially recognized by the Brazilian market in 2011 and this growth is expected to continue in the coming years.
- In Brazil, silver antimicrobial dressings rapid increased. As per the report, antimicrobial dressings grew rapidly, expanding 35% as silver-embedded dressings and hence became extremely popular with physicians.
- The antimicrobial dressing market includes dressings impregnated with silver, polyhexamethylene biguanide (PHMB), activated charcoal, and iodine to fight bacteria and infections of open wounds. The rise of antibiotic resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) is considered as a major driver for this market in both Brazil and Europe.
- In Brazil, there are some concerns regarding over-usage of silver dressings and their effectiveness as a primary dressing for the entire course of wound healing, and hence the there would be a decrease in growth.
- Whereas in Europe, silver dressings have come under scrutiny since the results of the VULCAN study were released in 2009.In 2012, the unit sales of silver dressings had increased to just over 5%, despite the products’ clinical effectiveness being called into question.
- In both Europe and Brazil, Ethicon has been a major competitor in the wound closure market. It holds a majority of the sutures market and the surgical stapling market mainly driven by its excellent marketing and sales force. In 2008, the company acquired Omrix and hence it became an inherited market share in the European thrombin-based haemostat segment.
- In the Brazil’s haemostat and tissue sealants market, Johnson & Johnson’s, Ethicon competes heavily with Covidien and Baxter. Takeda, a research-based global pharmaceutical company, carved a niche market for its single thrombin combination product in the tissue sealants market. A local Brazilian producer named Curatec has increased their share in the moist dressing segment by providing lower cost alternatives to the premium products in comparison with other major players such as Smith & Nephew.